Trial Profile
Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Pegmolesatide (Primary)
- Indications Anaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Jiangsu Hansoh Pharmaceutical
- 04 Dec 2015 New trial record